Suppr超能文献

miRNA-32 的神奇与奥秘。

Magic and mystery of microRNA-32.

机构信息

The First Affiliated Hospital, Department of Metabolism and Endocrinology, Hengyang Medical School, University of South China, Hengyang, China.

The First Affiliated Hospital, Department of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, China.

出版信息

J Cell Mol Med. 2021 Sep;25(18):8588-8601. doi: 10.1111/jcmm.16861. Epub 2021 Aug 18.

Abstract

MicroRNAs (miRNAs) are a group of endogenous, small (∼22 nts in length) noncoding RNA molecules that function specifically by base pairing with the mRNA of genes and regulate gene expression at the post-transcriptional level. Alterations in miR-32 expression have been found in numerous diseases and shown to play a vital role in cell proliferation, apoptosis, oncogenesis, invasion, metastasis and drug resistance. MiR-32 has been documented as an oncomiR in the majority of related studies but has been also verified as a tumour suppressor miRNA in conflicting reports. Moreover, it has a crucial role in metabolic and cardiovascular disorders. This review provides an in-depth look into the most recent finding regarding miR-32, which is involved in the expression, regulation and functions in different diseases, especially tumours. Additionally, this review outlines novel findings suggesting that miR-32 may be useful as a noninvasive biomarker and as a targeted therapeutic in several diseases.

摘要

MicroRNAs (miRNAs) 是一组内源性、小的(约 22 个核苷酸长)非编码 RNA 分子,通过与基因 mRNA 的碱基配对特异性地发挥作用,并在转录后水平调节基因表达。miR-32 表达的改变在许多疾病中被发现,并被证明在细胞增殖、凋亡、癌发生、侵袭、转移和耐药性中发挥重要作用。miR-32 在大多数相关研究中被认为是致癌 miRNA,但在相互矛盾的报告中也被证实是肿瘤抑制 miRNA。此外,它在代谢和心血管疾病中起着关键作用。这篇综述深入探讨了 miR-32 的最新发现,包括其在不同疾病,特别是肿瘤中的表达、调控和功能。此外,本综述还概述了新的发现,表明 miR-32 可能作为几种疾病的非侵入性生物标志物和靶向治疗具有潜在的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdd/8435424/0e93d241d05a/JCMM-25-8588-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验